Literature DB >> 22619929

Symptomatic leptomeningeal and entirely intramedullary spinal cord metastasis from supratentorial glioblastoma: a case report.

Dilok Tantongtip1, Pattarawit Rukkul.   

Abstract

BACKGROUND: Leptomeningeal with intramedullary spinal cord metastasis rarely occur. Most patients have dramatically poor prognosis. The causes of metastasis remain unclear and there is still no principle management for this aggressive tumor. CASE REPORT: The presentation report demonstrates the clinical features, the radiographic study and the histological characteristics in a 46-year-old woman who underwent surgical removal of a supratentorial glioblastoma and developed symptomatic spinal metastasis. The pathological report confirmed the diagnosis by laminectomy and intramedullary tumor biopsy. The analysis of the possible factors of metastasis and the management of this circumstance are discussed.
CONCLUSION: Spinal cord metastasis of Glioblastoma is one of the most poor prognostic factors. The most important precipitating factor is the location of the tumor which is located near the cerebrospinal fluid cistern. Magnetic resonance imaging of the whole spine should be considered in this group of patients.

Entities:  

Mesh:

Year:  2011        PMID: 22619929

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Brain Stem and Entire Spinal Leptomeningeal Dissemination of Supratentorial Glioblastoma Multiforme in a Patient during Postoperative Radiochemotherapy: Case Report and Review of the Literatures.

Authors:  Xiangyi Kong; Yu Wang; Shuai Liu; Keyin Chen; Qiangyi Zhou; Chengrui Yan; Huayu He; Jun Gao; Jian Guan; Yi Yang; Yongning Li; Bing Xing; Renzhi Wang; Wenbin Ma
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

Review 2.  Intracranial dissemination of glioblastoma multiforme: a case report and literature review.

Authors:  Keke Zhang; Yihang Yang; Jianfeng Zhuang; Gengyin Guo; Xin Chao; Zhen Zhang
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.